Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2023-05-25 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Proxy Form for the Solicitation of Voting Rights by Independent Non-Executive Director ("Independent Director's Proxy Form") for the Annual General Meeting of 2022
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Proxy Form for the solicitation of voting rights by an Independent Non-Executive Director for the Annual General Meeting (AGM) of Pharmaron Beijing Co., Ltd. It includes detailed voting instructions on various resolutions to be considered at the AGM, such as approval of the 2022 Annual Report, election of directors, remuneration, amendments to policies, and capital changes. The document is clearly related to the AGM process and is not the AGM presentation materials themselves, nor is it the actual Annual Report or financial statements. It is a proxy solicitation form used to vote at the AGM. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is not a brief announcement or a certification but a substantive proxy form for shareholder voting.
2023-05-25 English
Form of Proxy for the First H Share Class Meeting of 2023
AGM Information Classification · 95% confidence The document is a Form of Proxy for the First H Share Class Meeting of 2023 of Pharmaron Beijing Co., Ltd. It contains instructions for shareholders to appoint proxies to vote on various special resolutions at a shareholder meeting. The content is focused on voting procedures and resolutions to be considered at the meeting, which is typical of materials related to shareholder meetings. It is not a report of the meeting itself, nor is it a financial report or earnings release. It is also not a declaration of voting results but a proxy form used before the meeting. This type of document is best classified under AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or related shareholder meetings.
2023-05-25 English
Form of Proxy for the Annual General Meeting of 2022 (Applicable to H Shareholders)
AGM Information Classification · 95% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of Pharmaron Beijing Co., Ltd. for the year 2022. It includes detailed instructions for shareholders on how to appoint proxies to vote on various resolutions at the AGM, including election of directors, approval of financial statements, remuneration, and amendments to company policies. The content is focused on the meeting logistics and voting procedures rather than the actual reports or financial statements themselves. The document is not the Annual Report or any financial report but is related to the AGM process. Therefore, it fits the category of AGM Information (AGM-R). The document length is substantial (15,000 characters), indicating it is a full proxy form rather than a brief announcement or notice.
2023-05-25 English
NOTICE OF THE FIRST H SHARE CLASS MEETING OF 2023
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for the First H Share Class Meeting of 2023 of Pharmaron Beijing Co., Ltd. It includes details about the meeting date, location, agenda items such as profit distribution plan, share incentive scheme, capital increase, and repurchase of shares. It also contains proxy forms and instructions for shareholders to vote. The document is a formal announcement inviting shareholders to attend and vote on specific resolutions at a class meeting. It does not contain financial statements, audit results, or detailed management discussion and analysis. It is not a report but a notice of a shareholder meeting with voting matters. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and solicitation of voting rights (including proxy forms), it aligns best with Proxy Solicitation & Information Statement (PSI). The document length is over 10,000 characters, indicating it is a full notice and not a brief announcement. Hence, the classification is PSI with high confidence.
2023-05-25 English
NOTICE OF THE ANNUAL GENERAL MEETING OF 2022
AGM Information Classification · 100% confidence The document is a detailed notice of the Annual General Meeting (AGM) for Pharmaron Beijing Co., Ltd. It includes the date, location, agenda items such as approval of the 2022 Annual Report, appointment of directors, remuneration, profit distribution plan, and other corporate governance matters. It also contains proxy forms and instructions for shareholders to vote. The document is clearly a notice for the AGM, not the actual annual report or financial statements themselves. It is lengthy (15,000 characters) but primarily serves as an invitation and agenda for the AGM, which fits the definition of AGM Information (AGM-R).
2023-05-25 English
CIRCULAR FOR THE 2022 ANNUAL GENERAL MEETING AND 2023 FIRST H SHARE CLASS MEETING
AGM Information Classification · 95% confidence The document is a detailed circular from Pharmaron Beijing Co., Ltd. related to the Annual General Meeting (AGM) for the year 2022. It includes the work reports of the Board of Directors and Supervisory Committee, financial statements for 2022, the full text of the 2022 Annual Report, remuneration details, proposed amendments to policies and articles of association, appointment of directors, notices of the AGM and class meetings, and other related matters. The document is lengthy (15,000 characters) and contains substantive content typically presented to shareholders for decision-making at the AGM. It is not merely an announcement or a proxy solicitation but a comprehensive circular including the AGM agenda and supporting reports. Therefore, it fits the category of AGM Information (AGM-R).
2023-05-25 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.